Biogen-Sage Therapeutics postpartum depression pill priced at $15900
reuters.com
reuters.com
That's an immediate reject. Everyone is able to decide on how much risk their willing to take on, but I don't think it's controversial to conclude that it's ill-advised to administer a medication to infants without testing.
On the other hand PPD is associated with maternal suicide, HR 19.300 (95% confidence interval (CI): 5.977–62.255)[1]. While it's not possible to conclude that Zuranolone reducing PPD would also reduce maternal suicide, avoiding that HR is notable. How much would you pay to reduce avoid feeling so bad you successfully committed suicide?
Idea, meet execution.
How much does it cost to bring a drug to market and then manufacture and distribute it? If it was a $6 pill, this would simply have never been developed, let alone distributed to struggling mothers.
I think the high cost of drugs is a symptom of an ignored issue. The fact is that it costs an eye-watering sum to get something to market. Obviously not all of it is remediable, after all, someone still has to do the biology and science work in a state of the art lab to invent these things. But some of it is remediable. I remember a press conference by the head of the FDA during Covid, who proudly stated that the vaccine was going to be approved 10x faster than other drugs without compromising safety or efficacy. That's great! But if we aren't sacrificing safety or efficacy and getting new drugs 10x as fast, why isn't that standard operating procedure?
If it were to cost only $20m or $50m or $100m to get a new drug to market instead of up to $2 billion (current avg cost estimate per CBO.gov website), I imagine drugs would start at lower price points, and even if the free market didn't do its thing, regulating prices would be easier without defacto banning new drugs.
But this is just a simple economic argument. I am not a biochemical researcher, and I don't want Thalidomide to happen again. But as long as it costs $3-$10 billion to break even on new drugs, (let alone profit) I don't see how drug prices can get lower. It's just math.
And let’s not forget the part where a lot of costs are also subsidized by taxpayer dollars.
They also spend money making tiny tweaks to existing drugs that work just fine for the sole purpose of extending their patents and keeping drug prices as high as possible (https://en.wikipedia.org/wiki/Evergreening)
That says nothing about system bandwidth: if normally they would approve 10 drugs in N months, but now they threw all available resources on one project to get N/10, it would make sense.
[1] https://healthpolicy.usc.edu/evidence-base/how-did-the-publi...
It's profiteering, plain and simple.
Furthermore, developing drugs and bringing them to market is a long, expensive process.
You can calculate what % of mothers feel this way by selling it (no insurance) for 15k and see who buys it…
That probably requires rewinding society to where we all lived close to extended family.
Postpartum is typically a time of little sleep, rapidly changing hormones, and lots of lifestyle changes too. So postpartum depression is very common, and not something that is so trivial to solve.
Curious what the cost will be to governments and consumers in countries with socialized medicine and/or public health insurance.
So, by some definition, this $16k pill course is a bargain.